Tealwood Asset Management Inc Biomarin Pharmaceutical Inc Transaction History

Tealwood Asset Management Inc

$228 Million
Q3 2024

A detailed history of Tealwood Asset Management Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Tealwood Asset Management Inc holds 15,650 shares of BMRN stock, worth $969,204. This represents 0.48% of its overall portfolio holdings.

Number of Shares

15,650

Previous 12,147 28.84%

Holding current value

$969,204

Previous $1 Million 10.0%

% of portfolio

0.48%

Previous 0.6%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$69.02 - $93.84 $241,777 - $328,721	3,503 Added 28.84%	15,650 $1.1 Million
Q2 2024 Jul 09, 2024	SELL	$74.43 - $92.22 $4,019 - $4,979	-54 Reduced 0.44%	12,147 $1 Million
Q1 2024 Apr 11, 2024	SELL	$83.81 - $99.0 $18,857 - $22,275	-225 Reduced 1.81%	12,201 $1.07 Million
Q4 2023 Jan 08, 2024	SELL	$76.22 - $98.51 $24,619 - $31,818	-323 Reduced 2.53%	12,426 $1.2 Million
Q3 2023 Nov 08, 2023	SELL	$85.07 - $94.48 $23,309 - $25,887	-274 Reduced 2.1%	12,749 $1.13 Million
Q2 2023 Jul 26, 2023	SELL	$86.68 - $100.3 $20,196 - $23,369	-233 Reduced 1.76%	13,023 $1.13 Million
Q1 2023 Apr 12, 2023	SELL	$87.74 - $117.27 $13,775 - $18,411	-157 Reduced 1.17%	13,256 $1.29 Million
Q4 2022 Jan 17, 2023	SELL	$80.93 - $108.63 $92,745 - $124,489	-1,146 Reduced 7.87%	13,413 $1.39 Million
Q3 2022 Nov 16, 2022	SELL	$82.16 - $96.94 $3,532 - $4,168	-43 Reduced 0.29%	14,559 $1.23 Million
Q2 2022 Jul 20, 2022	SELL	$71.48 - $86.85 $26,304 - $31,960	-368 Reduced 2.46%	14,602 $1.21 Million
Q1 2022 May 02, 2022	SELL	$74.28 - $92.69 $18,124 - $22,616	-244 Reduced 1.6%	14,970 $1.15 Million
Q4 2021 Mar 15, 2022	BUY	$71.72 - $91.47 $1.09 Million - $1.39 Million	15,214 New	15,214 $1.34 Million

Others Institutions Holding BMRN

# of Institutions

636

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tealwood Asset Management Inc with notifications on news.

Account

Tealwood Asset Management Inc Biomarin Pharmaceutical Inc Transaction History